2018 American Transplant Congress
A Research-Informed Framework for a Medication Adherence Intervention to Support Transition of Adolescent Kidney Recipients to Independent Medication-Taking
1University of Pittsburgh, Pittsburgh, PA; 2MUHC, McGill, Montreal, QC, Canada.
Purpose: Understand the needs and preferences of adolescent/young adult kidney recipients (12-24y), parents, and healthcare professionals (HCP), to inform adaptation of an efficacious adherence-promoting intervention…2018 American Transplant Congress
Frailty and Kidney Transplantation: AST-KPCOP Survey of Center Practices
Kidney Pancreas COP, AST, Mt. Laurel.
Background: Frailty is a clinical phenotype of decreased physiologic reserve and resistance to stressors. Given the potential utility of frailty evaluation as prognosticator of kidney…2018 American Transplant Congress
Urinary Proteomic Biomarkers for Prediction of Chronic Antibody-Mediated Rejection in Kidney Transplant Recipients
Background: Chronic antibody-mediated rejection (CAMR) is a challenging issue associated with allograft loss in kidney transplant recipients (KTRs) undergoing long-term follow-up. Changes in the urinary…2018 American Transplant Congress
Machine Learning to Assess Kidney Donor Risk
Thomas Jefferson University, Philadelphia, PA.
Organ quality estimation is critical in allocation and organ acceptance in renal transplantation. Standard methods determine the likelihood of an outcome of interest utilizing Cox…2018 American Transplant Congress
Identification of Novel Genetic Variants Associated with Tacrolimus Metabolism in Kidney Transplant Recipients Using Next Generation Sequencing
Tacrolimus (Tac) pharmacogenomics studies have identified common genetic variants that alter Tac troughs and developed specific dosing strategies for specific populations. Known common variants and…2018 American Transplant Congress
Presence of Chronic Vascular Lesions on Allograft Biopsy is Associated with Greater Improvement in Renal Function after Conversion from Tacrolimus to Belatacept
Background: Conversion from tacrolimus to belatacept has been shown to be beneficial for an increasing number of kidney transplant (KT) patients. However, predicting factors for…2018 American Transplant Congress
Prolonged-Release Tacrolimus Dosing in De Novo Kidney Transplantation: Randomized, Open-Label, Pilot Study
A multicenter, randomized, open-label, parallel-group, pilot, 52-wk study in Asian countries that assessed renal function, efficacy, and safety of low vs standard-dose prolonged-release tacrolimus (PRT)…2018 American Transplant Congress
Outcomes in Living Kidney Transplant Donor and Recipient Operations with Same vs. Different Surgeons
Introduction: Living Kidney Transplantation (LKT) has provided a means of increasing the organ pool for patients with end-stage renal disease (ESRD). Surgical practices vary regarding…2018 American Transplant Congress
Impact of an Anastomosis Time on Transplant Outcomes in Deceased Donor Kidney Transplantation
Internal Medicine, Kyungpook National University School of Medicine, Daegu, Republic of Korea.
Background: It is known that the increase in anastomosis time (AT) in deceased donor kidney transplantation (DDKT) is associated with increased incidence of delayed graft…2018 American Transplant Congress
Role of BK Virus-Specific T Cell Immune Monitoring for BK Virus-Associated Nephropathy in Kidney Transplant Recipients
Background: Reduced immunosuppression in a key therapy for BK virus (BKV)-associated nephropathy (BKVAN) in kidney transplant (KT) recipients. A study of immune monitoring against BKV…
- « Previous Page
- 1
- …
- 267
- 268
- 269
- 270
- 271
- …
- 531
- Next Page »